Funding Rounds
IO Biotech Series B (2021, $154M)
IO BiotechClinical-stage biotech company developing immune therapies for cancer treatment.
Summary
Stage: Series B
Raised Amount: $154.46M
Raised Date: 2021-01-01
Stage: Series B
Raised Amount: $154.46M
Raised Date: 2021-01-01
